CS
MRNA icon

Comerica Securities’s Moderna MRNA Stock Holding History

Comerica Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,094
Closed -$196K – 1049
2022
Q4 		$196K Buy
+1,094
New +$179K 0.01% 478
2022
Q1 		– Sell
-886
Closed -$225K – 515
2021
Q4 		$225K Buy
886
+187
+27% +$54.7K 0.01% 469
2021
Q3 		$269K Buy
+699
New +$258K 0.02% 429

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Comerica Securities's MRNA Position: Q1 2023 in Review

Comerica Securities sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,094 shares — an estimated $196K sold.

Comerica Securities first reported a position in MRNA in Q3 2021 and held it in 3 quarters. The position peaked at $269K in Q3 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Comerica Securities reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Comerica Securities sold 1,094 Moderna shares in Q1 2023, an estimated $196K.
  • Comerica Securities first reported a position in Moderna in Q3 2021 and held it in 3 quarters.
  • Comerica Securities's Moderna position peaked at $269K in Q3 2021.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.